Microbicidal efficacy 

Having undergone vigorous testing against a wide range of microorganisms and validated in line with global standards you can have complete confidence in the Antigermix technology.


To order to obtain TGA within Australia, mandatory testing and evidence must be submitted and assessed by the TGAs Biologics team. Manufacturers are required to submit microbiological efficacy testing on mandatory micro-organisms. Germitec testing is conducted through external testing facilities to remove any bias. This is the gold standard in supplying HLD disinfection products Class IIb to the Australian healthcare market with microbiological efficacy testing documents supplied by independent testing facilities. 

Mandatory testing completed for TGA includes:

Screen Shot 2019-12-09 at 10.32.41 pm.png

More than just High Level Disinfection.

The Antigermix􏰀 was tested using the European standard for "dirty conditions" which evaluated the disinfection process using a bacterial load that is 10 times greater than the "clean conditions" adapted to the disinfectants.

These tests were carried out with Mycobacterium terrae and show a complete reduction in accordance with the performance standards for high level disinfection.

Human papillomaviruses (HPV) are responsible for over 5% of human cancers worldwide. Nearly all cases of cervical cancer are the result of HPV infection, as well as a significant number of anogenital and oropharyngeal cancers.

The Antigermix has proven effectiveness of high-level UVC to deactivate HPV16 and HPV18.

In the spirit of always evaluating the limits, additional tests were carried out in the following circumstances:

  • Each UV-C tube was stained with a Brown stain.

  •  The reflective walls were stained with a Brown stain.

  • The quartz plate was stained with a Brown stain.

  • Contamination of the germ carrier is covered with a thin layer of ultrasound gel.

The results showed the Antigermix retained full efficacy even in sub-optimal simulated conditions.